Free Trial

MeiraGTx (MGTX) Stock Price, News & Analysis

MeiraGTx logo
$7.30 -0.19 (-2.54%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$7.30 0.00 (0.00%)
As of 08/29/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MeiraGTx Stock (NASDAQ:MGTX)

Key Stats

Today's Range
$7.24
$7.69
50-Day Range
$6.31
$8.89
52-Week Range
$3.85
$8.98
Volume
242,016 shs
Average Volume
335,274 shs
Market Capitalization
$587.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00
Consensus Rating
Buy

Company Overview

MeiraGTx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
91st Percentile Overall Score

MGTX MarketRank™: 

MeiraGTx scored higher than 91% of companies evaluated by MarketBeat, and ranked 101st out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MeiraGTx has only been the subject of 1 research reports in the past 90 days.

  • Read more about MeiraGTx's stock forecast and price target.
  • Earnings Growth

    Earnings for MeiraGTx are expected to grow in the coming year, from ($1.48) to $0.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MeiraGTx is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MeiraGTx is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MeiraGTx has a P/B Ratio of 182.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MeiraGTx's valuation and earnings.
  • Percentage of Shares Shorted

    4.44% of the float of MeiraGTx has been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in MeiraGTx has recently decreased by 7.04%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MeiraGTx does not currently pay a dividend.

  • Dividend Growth

    MeiraGTx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.44% of the float of MeiraGTx has been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in MeiraGTx has recently decreased by 7.04%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MeiraGTx has a news sentiment score of 1.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for MeiraGTx this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $583,055.00 in company stock.

  • Percentage Held by Insiders

    Only 7.50% of the stock of MeiraGTx is held by insiders.

  • Percentage Held by Institutions

    67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MeiraGTx's insider trading history.
Receive MGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MGTX Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel
See More Headlines

MGTX Stock Analysis - Frequently Asked Questions

MeiraGTx's stock was trading at $6.09 on January 1st, 2025. Since then, MGTX stock has increased by 19.9% and is now trading at $7.30.

MeiraGTx Holdings PLC (NASDAQ:MGTX) issued its earnings results on Thursday, August, 14th. The company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.52) by $0.04. The company earned $3.69 million during the quarter, compared to the consensus estimate of $8 million. MeiraGTx had a negative net margin of 415.39% and a negative trailing twelve-month return on equity of 314.44%.

MeiraGTx (MGTX) raised $75 million in an initial public offering on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager.

MeiraGTx's top institutional shareholders include Perceptive Advisors LLC (15.71%), Adage Capital Partners GP L.L.C. (7.51%), Rubric Capital Management LP (4.64%) and 683 Capital Management LLC (3.35%). Insiders that own company stock include Perceptive Advisors Llc, Alexandria Forbes and Richard Giroux.
View institutional ownership trends
.

Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA).

Company Calendar

Last Earnings
8/14/2025
Today
8/31/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MGTX
CIK
1735438
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$13.00
Potential Upside/Downside
+228.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$147.79 million
Net Margins
-415.39%
Pretax Margin
-415.39%
Return on Equity
-314.44%
Return on Assets
-63.28%

Debt

Debt-to-Equity Ratio
26.29
Current Ratio
0.88
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$33.28 million
Price / Sales
17.65
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
182.50

Miscellaneous

Outstanding Shares
80,450,000
Free Float
74,413,000
Market Cap
$587.29 million
Optionable
Optionable
Beta
1.25

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MGTX) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners